Diclofenac topical Alternatives Compared
Diclofenac topical | Tramadol | Gabapentin |
|
---|
Diclofenac topical | Tramadol | Gabapentin |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription and OTC
Prescribed for Back Pain, Osteoarthritis, Keratosis, Pain. Diclofenac topical may also be used for purposes not listed in this medication guide. |
Prescription only
Tramadol is a strong opioid pain relieving medication that may be used to treat moderate to severe general and nerve-related pain. Tramadol may be habit-forming and misuse can cause addiction... View more |
Prescription only
Gabapentin is an anticonvulsant with pain-relieving effects that may be used to treat certain seizure disorders or relieve nerve pain. Common side effects include dizziness or drowsiness and it may... View more |
Related suggestions |
|||||||||||||||||||||||
More about Diclofenac topical | More about Tramadol | More about Gabapentin | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Diclofenac topical has an average rating of 7.0 out of 10 from a total of 463 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 25% reported a negative effect. |
Tramadol has an average rating of 7.0 out of 10 from a total of 1861 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 24% reported a negative effect. |
Gabapentin has an average rating of 7.2 out of 10 from a total of 2547 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 21% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
Lower cost generic |
Lower cost generic |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Diclofenac topical prices |
View all Tramadol prices |
View all Gabapentin prices |
||||||||||||||||||||||||
Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Aspercreme Arthritis Pain Relief Gel, Diclozor, Flector Patch, Licart, Pennsaid, Profinac, Solaraze, Voltaren Arthritis Pain Gel, Xrylix View more | ConZip, Qdolo, Tramadol Hydrochloride ER | Fanatrex, Gabarone, Gralise, Neurontin | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
1.8 hours |
5.2 hours |
6 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
Prior To 30 Weeks Gestation
Category D
Positive evidence of risk
Starting At 30 Weeks Gestation See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 123 drugs are known to interact with Diclofenac topical:
|
A total of 688 drugs are known to interact with Tramadol:
|
A total of 270 drugs are known to interact with Gabapentin:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
October 16, 2000 |
March 03, 1995 |
December 30, 1993 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.